Progyluton, which is used to treat menstrual irregularities, is a low-dosage medication that is indicated for regulating the periods in young women and for hormone replacement therapy HRT in older, menopausal or post-menopausal women, according to Shared Journey. When dosages are discontinued in younger women, the period usually returns in seven days.
Because the dosages of progesterone and estrogen in progyluton are so low, the medicine cannot be taken as a contraceptive. Therefore, Shared Journey explains that obstetricians and gynecologists often recommend the drug for abnormal uterine bleeding. Therapeutically, progyluton can be used in HRT as well as to treat and prevent postmenopausal osteoporosis. The drug is regularly used to treat primary and secondary amenorrhea.
Using the drug for HRT should be stopped if the patient is pregnant or lactating, has been diagnosed with or suspects she may have breast cancer or has undiagnosed vaginal bleeding, according to Farmacia Del Niño. The medication should also not be taken by women who have liver disease or a history of cardiovascular conditions, such as heart disease, clots or stroke. Women with high levels of triglycerides should also refrain from taking the medicine. To regulate the menstrual cycle, progyluton therapy is typically started on the fifth day of the menstrual cycle. Patients who have amenorrhea who experience an occasional post-menopausal period can undergo the therapy at any time. The active ingredient in progyluton is estradiol-norgestrel.